Regarding tumor subtype, a prevalence of luminal tumors was found (30% of patients presented luminal A tumors, 20% were triple negative, 26.6% had HER2 enriched, and 23.4% were typed as luminal B). The gene discussed is ERBB2; the disease is neoplasm.